+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nucleic Acid Amplification Testing Market by Technology (Isothermal Amplification, Polymerase Chain Reaction), Product Type (Instruments, Reagents & Kits, Software & Services), End User, Application - Global Forecast 2025-2030- Product Image
Nucleic Acid Amplification Testing Market by Technology (Isothermal Amplification, Polymerase Chain Reaction), Product Type (Instruments, Reagents & Kits, Software & Services), End User, Application - Global Forecast 2025-2030- Product Image
Sale

Nucleic Acid Amplification Testing Market by Technology (Isothermal Amplification, Polymerase Chain Reaction), Product Type (Instruments, Reagents & Kits, Software & Services), End User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460252
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The nucleic acid amplification testing market is undergoing a profound transformation as innovations in technology, evolving healthcare demands, and shifting regulatory policies reshape its global landscape. Senior leaders seeking data-driven guidance on market positioning, growth strategies, and operational resiliency will find comprehensive, actionable insights in this independent report.

Market Snapshot: Nucleic Acid Amplification Testing Sector

The nucleic acid amplification testing market grew from USD 3.53 billion in 2024 to USD 4.00 billion in 2025. It is projected to expand at a CAGR of 12.90% to reach USD 7.31 billion by 2030. This robust growth is driven by rising demand for advanced diagnostic solutions, increasing adoption of point-of-care testing, and a rapidly shifting need for timely detection of infectious diseases and precision medicine applications. Supply chain realignments and ongoing regulatory evolution continue to impact strategic decisions as companies navigate new operational realities.

Scope & Segmentation

This market analysis delivers a thorough assessment of current trends, innovations, and challenges, structured across clearly defined segmentation parameters:

  • Technologies: Isothermal amplification methods such as helicase dependent, loop mediated, nucleic acid sequence based, strand displacement, and transcription mediated amplification; and polymerase chain reaction modalities, including digital PCR and real time PCR.
  • Product Types: Instruments (benchtop and portable), reagents & kits (buffers, enzymes, master mixes, primers & probes), and software & services (data analysis, maintenance & support, training & consulting).
  • End Users: Diagnostic laboratories, hospitals, point-of-care testing sites, and research institutes.
  • Applications: Companion diagnostics, genetic testing (carrier screening, prenatal, rare disease), infectious disease detection (bacterial, parasitic, viral), and oncology (biomarker testing, minimal residual disease, mutation analysis).
  • Regional Markets: Americas (key U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and more).
  • Company Coverage: Insights on leading players, including Roche Holding AG, Abbott Laboratories, QIAGEN N.V., Thermo Fisher Scientific Inc., Danaher Corporation, bioMérieux SA, Hologic, Siemens Healthineers, Becton, Dickinson and Company, and PerkinElmer.

Key Takeaways for Senior Decision-Makers

  • Stakeholders are adopting integrated digital platforms to enhance diagnostic accuracy, data analytics, and actionable reporting in nucleic acid amplification testing.
  • Isothermal amplification protocols are enabling rapid and decentralized diagnostics, especially in resource-limited and point-of-care settings.
  • Automation of sample preparation and connectivity with cloud-based software is streamlining laboratory workflows and reducing operational complexity.
  • Collaborative partnerships between reagent suppliers, instrument manufacturers, and software developers are accelerating the translation of research into clinical solutions.
  • Increased emphasis on modular and interoperable systems allows flexibility in sourcing, regulatory compliance, and platform extensibility for a diverse range of clinical and research users.
  • Comprehensive training, maintenance support, and open-source development opportunities are raising performance standards and expanding market accessibility.

Impact of 2025 United States Tariff Measures

Anticipated U.S. tariffs on imported polymerases, primers, reagents, and proprietary instrument components will place significant cost pressures across the supply chain. Companies with diversified sourcing strategies and established regional partnerships are better equipped to navigate logistical disruptions and sustain operational continuity, while those dependent on cross-border suppliers may face higher input costs and compressed margins. Proactive supply chain resilience efforts and local manufacturing exploration are now becoming strategic imperatives in response to these external pressures.

Rigorous Research Methodology & Trusted Data Sources

This analysis utilizes a robust blend of qualitative and quantitative research, including thorough reviews of peer-reviewed publications, patents, regulatory filings, and structured interviews with more than fifty industry thought leaders. Quantitative market sizing and scenario modeling support data triangulation and ensure results are actionable and reliable.

Why This Report Matters

  • Delivers a clear framework for strategic decision-making with actionable insights tailored to the nucleic acid amplification testing sector.
  • Supports risk assessment and investment planning amid evolving global operational and geopolitical pressures.
  • Highlights key technology, product, and regional factors affecting future growth and competitive positioning.

Conclusion

This report clarifies the foundational and forward-looking dynamics shaping nucleic acid amplification testing worldwide. Executives can utilize these insights to refine market approaches, optimize supply chain strategies, and identify new opportunities in a continually evolving diagnostics ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of point-of-care NAAT devices with smartphone-based diagnostics and telehealth platforms
5.2. Development of multiplexed assays for simultaneous detection of multiple respiratory pathogens
5.3. Adoption of CRISPR-based isothermal amplification technologies for ultra-sensitive viral RNA analysis
5.4. Regulatory approvals and emergency use authorizations expanding decentralized COVID-19 molecular testing access
5.5. Rising use of digital microfluidics to automate sample preparation and amplification in compact cartridges
5.6. Growth in adoption of PCR-based molecular panels for sexually transmitted infection screening at primary care
5.7. Investment in portable thermal cyclers powered by solar energy for field-based pathogen surveillance
5.8. Implementation of automated high-throughput NAAT workflows in central laboratories for mass screening
5.9. Emergence of novel nanopore-based isothermal techniques combining real-time analysis and amplification
5.10. Collaboration between diagnostics companies and telemedicine platforms to enable at-home molecular testing
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Nucleic Acid Amplification Testing Market, by Technology
8.1. Introduction
8.2. Isothermal Amplification
8.2.1. Helicase Dependent Amplification
8.2.2. Loop Mediated Amplification
8.2.3. Nucleic Acid Sequence Based Amplification
8.2.4. Strand Displacement Amplification
8.2.5. Transcription Mediated Amplification
8.3. Polymerase Chain Reaction
8.3.1. Digital Polymerase Chain Reaction
8.3.2. Real Time Polymerase Chain Reaction
9. Nucleic Acid Amplification Testing Market, by Product Type
9.1. Introduction
9.2. Instruments
9.2.1. Benchtop Instruments
9.2.2. Portable Instruments
9.3. Reagents & Kits
9.3.1. Buffers
9.3.2. Enzymes
9.3.3. Master Mixes
9.3.4. Primers & Probes
9.4. Software & Services
9.4.1. Data Analysis Software
9.4.2. Maintenance & Support
9.4.3. Training & Consulting Services
10. Nucleic Acid Amplification Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals
10.4. Point Of Care Testing
10.5. Research Institutes
11. Nucleic Acid Amplification Testing Market, by Application
11.1. Introduction
11.2. Companion Diagnostics
11.3. Genetic Testing
11.3.1. Carrier Screening
11.3.2. Prenatal Genetic Testing
11.3.3. Rare Disease Diagnostics
11.4. Infectious Disease
11.4.1. Bacterial Infectious Disease
11.4.2. Parasitic Infectious Disease
11.4.3. Viral Infectious Disease
11.5. Oncology
11.5.1. Biomarker Testing
11.5.2. Minimal Residual Disease Detection
11.5.3. Mutation Analysis
12. Americas Nucleic Acid Amplification Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Nucleic Acid Amplification Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Nucleic Acid Amplification Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Roche Holding AG
15.3.2. Abbott Laboratories
15.3.3. QIAGEN N.V.
15.3.4. Thermo Fisher Scientific Inc.
15.3.5. Danaher Corporation
15.3.6. bioMérieux SA
15.3.7. Hologic, Inc.
15.3.8. Siemens Healthineers AG
15.3.9. Becton, Dickinson and Company
15.3.10. PerkinElmer, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NUCLEIC ACID AMPLIFICATION TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NUCLEIC ACID AMPLIFICATION TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NUCLEIC ACID AMPLIFICATION TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NUCLEIC ACID AMPLIFICATION TESTING MARKET: RESEARCHAI
FIGURE 24. NUCLEIC ACID AMPLIFICATION TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. NUCLEIC ACID AMPLIFICATION TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. NUCLEIC ACID AMPLIFICATION TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NUCLEIC ACID AMPLIFICATION TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY HELICASE DEPENDENT AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY HELICASE DEPENDENT AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY LOOP MEDIATED AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY LOOP MEDIATED AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PORTABLE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PORTABLE INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BUFFERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BUFFERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MASTER MIXES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MASTER MIXES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRIMERS & PROBES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRIMERS & PROBES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRENATAL GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRENATAL GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY RARE DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY RARE DISEASE DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PARASITIC INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PARASITIC INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY VIRAL INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY VIRAL INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MINIMAL RESIDUAL DISEASE DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MINIMAL RESIDUAL DISEASE DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MUTATION ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MUTATION ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 161. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 166. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 167. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 170. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 171. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 172. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 173. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 174. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 175. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 180. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 181. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 182. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 183. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 184. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 185. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 188. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 189. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 190. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 191. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 198. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 199. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 204. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 205. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 206. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 207. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 208. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 282. EU

Samples

Loading
LOADING...

Companies Mentioned

  • Roche Holding AG
  • Abbott Laboratories
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • bioMérieux SA
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.31 Billion
Compound Annual Growth Rate12.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Isothermal Nucleic Acid Amplification Technology Market by Product Type (Instruments, Reagents & Kits, Software & Services), Workflow (Amplification, Detection & Analysis, Preanalytical), Platform, Technology, End User, Application - Global Forecast 2025-2030 - Product Image

Isothermal Nucleic Acid Amplification Technology Market by Product Type (Instruments, Reagents & Kits, Software & Services), Workflow (Amplification, Detection & Analysis, Preanalytical), Platform, Technology, End User, Application - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Nucleic Acid Amplification Testing Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report (2025-2034) - Product Image

Nucleic Acid Amplification Testing Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Nucleic Acid Amplification Testing Market Report 2025 - Product Image

Nucleic Acid Amplification Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Nucleic Acid Amplification Testing Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F - Product Image

Nucleic Acid Amplification Testing Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Isothermal Nucleic Acid Amplification Technology Market Size, Share, Trends and Forecast by Product, Technology, Application, End-User, and Region, 2025-2033 - Product Image

Isothermal Nucleic Acid Amplification Technology Market Size, Share, Trends and Forecast by Product, Technology, Application, End-User, and Region, 2025-2033

  • Report
  • 139 Pages
  • Global
From

About the Nucleic Acid Amplification Test Market

The Nucleic Acid Amplification Test (NAAT) market is a segment of the In Vitro Diagnostics (IVD) industry. NAATs are used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. These tests are used to diagnose and monitor a wide range of infectious diseases, including HIV, hepatitis, and tuberculosis. NAATs are also used to detect genetic mutations associated with cancer and other inherited diseases. NAATs are highly sensitive and specific, and can be used to detect very small amounts of nucleic acid. This makes them ideal for use in clinical settings, where rapid and accurate diagnosis is essential. NAATs are also used in research and public health settings, where they can be used to monitor the spread of infectious diseases. The NAAT market is highly competitive, with many companies offering a range of products. Some of the major players in the market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Cepheid, and Hologic. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.